Inventor · disambiguated record
Christopher Michael Haqq
Also filed as: HAQQ CHRISTOPHER · HAQQ CHRISTOPHER M · HAQQ CHRISTOPHER MICHAEL
4 granted patents·10 pending applications·7 citations·filing 2007–2023
64Inventor score
Files withSANTA MARIA BIOTHERAPEUTICS INC5AMGEN INC4UNIV CALIFORNIA2BELTRAN PEDRO J1ELICIO THERAPEUTICS INC1
Top patents by PatentIndex Score
14 records- 0176US12383572B2Administration of an anti-activin-a compound to a subjectAMGEN INC·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 0273US8492102B2Molecular diagnosis and classification of malignant melanomaKASHANI-SABET MOHAMMED·Filed 2009·Granted Jul 23, 2013·7 cites·9 claims
- 0371US11541070B2Administration of an anti-activin-A compound to a subjectAMGEN INC·Filed 2019·Granted Jan 3, 2023·0 cites·1 claims
- 0464US2024277805A1Formulated receptor polypeptides and related methodsSANTA MARIA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0551US2013344481A1Molecular diagnosis and classification of malignant melanomaUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 0650US2015359850A1Administration of an anti-activin-a compound to a subjectSANTA MARIA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0749US11078288B2Methods and compositions for treating tumor diseasesAMGEN INC·Filed 2018·Granted Aug 3, 2021·0 cites·20 claims
- 0845US2010166747A1Methods and compositions for treating tumor diseasesBELTRAN PEDRO J·Filed 2008·Application pending·0 cites
- 0945US2023263882A1Compositions and methods for inducing an immune response against coronavirusELICIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1042US2011159496A1Molecular diagnosis and classification of malignant melanomaUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 1140US2014220033A1Administration of an Anti-Activin-A Compound to a SubjectSANTA MARIA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1239US2016038588A1Myostatin Antagonism in Human SubjectsAMGEN INC·Filed 2014·Application pending·0 cites
- 1338US2017202909A1Formulated Receptor Polypeptides and Related MethodsSANTA MARIA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1430US2016333418A1Activin Inhibitor Response Prediction and Uses for TreatmentSANTA MARIA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Michael Haqq files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →